mCig Inc. Signs Letter of Intent with multi-state licensed PCAB accredited compounding, retail, and specialty pharmacy network.
JACKSONVILLE, FL, March, 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy (http://www.medicalhomepharmacy.com/,
Kaplan Group has an extensive history designing personalized, patient-centric programs enhancing health outcomes and experience, and has developed close relationships with hospitals and health systems, community physician practices, among other community referral sources.
Kaplan Group is known for referring hospitals and physicians to innovative research and program development, bringing personalized solutions with a strong track record of driving enhanced patient engagement, health outcomes and satisfaction scores.
Kaplan Group has cultivated patient trust and loyalty that is key to uninhibited patient engagement which will lead to early adoption of (cutting edge) health and wellness solutions. With over four decades of experience, Kaplan Group owns, and operates, state of the art pharmacies equipped with specialty dispensing, and compounding labs, robotic dispensing, and patient friendly packaging solutions.
Whether servicing high risk, medically complex patients, or those with minimal needs, the approach is always to optimize the unique health and wellness potential for the individual.
Kaplan Group also brings strategic access to international markets, including a network of countries serviced by a centrally located Medical Tourism program.
Ahmet Ugur, an advisor for Kaplan Group states: “Kaplan Group is cultivating relationships with large employers, and labor unions, and will be applying their expertise at a population management level. They’re also exploring new opportunities in research and product development, supply chain management and clinical studies, to offer personalized, precision health and wellness solutions. Accordingly, larger markets will allow for leveraging of scalable, personalized technologies, and disruptive solutions, leading to mutually beneficial opportunities for both parties.”
Accordingly, Kaplan Group sees this aligning very strategically with MCIG’s interest in integrating health & wellness solutions, with access to larger populations.
Paul Rosenberg, MCIG’s Chief Executive Officer, said: “We are excited to partner exclusively with Kaplan Group. MCIG’s strategy is to build a strategic ecosystem of products and services to address the health and wellness multi-billion dollar market that Kaplan Group will sell, promote, and track the outcomes. Kaplan Group brings to the marketplace breakthrough products with cutting edge technologies, and services, this will provide huge opportunities that MCIG looks very much forward to being a part of.”
About MCIG Group
Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.
The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.
Visit us on Facebook @ https://www.facebook.com/mCigInc/
Follow us on Twitter @mcigInc
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.